30TH ANNIVERSARY RUSSIAN PHARMACEUTICAL FORUM NAMED AFTER N.A. SEMASHKO

On May 16-17, 2023, the 30th anniversary Russian Pharmaceutical Forum named after N.A. Semashko will be held in St. Petersburg at the Corinthia Hotel (+online).

The heads of leading international and Russian pharmaceutical companies, scientific organizations, patient communities and other industry experts will come together again.

The Forum is being held with the support of the State Institute of Medicines and Good Practices of the Ministry of Industry and Trade of Russia.

AMONG THE KEY TOPICS OF THE FORUM 2023:

•  Ensuring the stability of the pharmaceutical market and maintaining drug availability. Best practices from pharmaceutical business leaders;

•  Business solutions that have proven their effectiveness during the sanctions period;

•  Dialogue between regulators and business. Creating a precedent - measures of state support for the pharmaceutical industry and prospects for the development of the system;

•  Round table "Technological sovereignty";

•  Commercial drug market in the current realities. Development of the retail and distribution segments;

•  Dynamics of the dietary supplements market;

•  Analytics: global and local pharmaceutical trends and forecasts;

•  Open meeting of the public council of Roszdravnadzor “DRUG PROVISION. response to patient complaints;

•  Digital Pharma, pharmaceutical E-commerce, marketing strategies in RX, OTC and dietary supplements;

•  Trends and problems of innovative development of the Russian pharmaceutical industry. State and prospects of the R&D market in Russia.

MARKET OVERVIEW 360 DEGREES FROM THE TOP PERSONS OF COMPANIES, AMONG SPEAKERS:

•  Alexander Semenov, President, Shareholder, Active Component;

•  Alexey Alekhin, Advisor to the Minister of Industry and Trade of the Russian Federation;

•  Alla Samoilova, Head of the Federal Service for Surveillance in Healthcare;

•  Boris Popov, General Director, Zdravcity;

•  Vladislav Shestakov, Director of the FBU "State Institute of Medicines and Good Practices" of the Ministry of Industry and Trade of Russia;

•  Denis Chetverikov, President, Akrikhin;

•  Evgenia Shapiro, General Director, RUS BioPharm;

•  Igor Obrubov, General Director, Rusatom Healthcare;

•  Mikhail Stepanov, CEO, Irvine.

•  Natalia Prokopieva, Chairman of the Board of Directors, Evalar;

•  Petr Rodionov, General Director, Geropharm;

•  Rustem Muratov, CEO and Member of the Board of Directors, Binnopharm Group;

The full program, speakers and conditions of participation are available on the website.